5-Amino-1MQ has not been approved by the FDA or any regulatory agency for human use
The strongest published finding is from the foundational Biochemical Pharmacology study by Neelakantan et al.: in diet-induced obese mice, daily 5-Amino-1MQ administration produced reductions in body weight, white adipose tissue mass, and adipocyte size without any significant change in food intake
These processes integrate the perception and interpretation of visual information with memory and executive systems by involving various brain areas, including the occipito-parietal regions, the dorsal and ventral streams, and connections with the cingulate, medial temporal, and frontal cortices 7
If you take the peptide at 7am some days and 11am other days, you create variable metabolic conditions that make dose optimization impossible
There are some circumstances where deviating from NICE guidelines may be acceptable
Pain Pract., 20 , 838849